Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo

Georg Widera, Melissa A. Austin, Dietmar Rabussay, +8

The Journal of Immunology

VaccinationCombination Hiv GagCross-protectionMucosal VaccinationVaccine Development +9

<i>In Vitro</i> Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and <i>In Vivo</i> Toxicology in Non-Human Primates

Changyu Wang, Kent Thudium, Minhua Han, +15

Cancer Immunology Research

Vaccination of chimpanzees against infection by thehepatitis C virus.

Q L Choo, George Kuo, Robert Ralston, +7

Proceedings of the National Academy of Sciences

VaccinationControl ChimpanzeesVeterinary VaccineVaccine DevelopmentViral Hepatitis +10

Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy

Ariel E. Marciscano, Ali Ghasemzadeh, Thomas R. Nirschl, +18

Clinical Cancer Research

Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology

Mark Selby, John Engelhardt, Robert J. Johnston, +10

PLoS ONE

ImmunologyPathologyImmunotherapeuticsImmunotherapyTumor Biology +16

Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses

Robert Ralston, Kent Thudium, Karin Berger, +7

Journal of Virology

Virus StructureMolecular VirologyBiochemistrySynthetic VirologyNatural Sciences +12

An Alphavirus Replicon Particle Chimera Derived from Venezuelan Equine Encephalitis and Sindbis Viruses Is a Potent Gene-Based Vaccine Delivery Vector

Silvia Perri, Catherine E. Greer, Kent Thudium, +10

Journal of Virology

Efficacy of BMS-986016, a monoclonal antibody that targets lymphocyte activation gene-3 (LAG-3), in combination with nivolumab in pts with melanoma who progressed during prior anti–PD-1/PD-L1 therapy (mel prior IO) in all-comer and biomarker-enriched populations

Paolo A. Ascierto, Petri Bono, Shailender Bhatia, +15

Annals of Oncology

Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells

Richard R. Spaete, D’Anna Alexander, Mary E. Rugroden, +11

Virology

Viral ReplicationHepatitis CViral HepatitisMedicineNatural Sciences +8

Preclinical Characterization of Relatlimab, a Human LAG-3–Blocking Antibody, Alone or in Combination with Nivolumab

Kent Thudium, Mark Selby, Julie A. Zorn, +6

Cancer Immunology Research

Ligands Mhc IiImmunologyImmunodominanceImmunologic MechanismAntigen Processing +18